SCHEMBL31332297

CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21)C(N)=O

nearest known ligand 0.56

Predicted protein targets (top 6)

	gene	UniProt	supporting neighbours	confidence
▸	NMUR2	Q9GZQ4	3/20	0.56

▸	NMUR1	Q9HB89	2/20	0.56

▸	OPRD1	P41143	6/20	0.56

▸	APLNR	P35414	2/20	0.54

▸	NTSR1	P30989	1/20	0.52

▸	PIN1	Q13526	1/20	0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
Substance P SCHEMBL18769078	0.87	OPRD1 (0.67)	NMUR2NMUR1OPRD1
Substance P SCHEMBL19057679	0.87	OPRD1 (0.67)	NMUR2NMUR1OPRD1
Substance P SCHEMBL1116347	0.87	OPRD1 (0.67)	NMUR2NMUR1OPRD1
Substance P SCHEMBL29831869	0.87	OPRD1 (0.67)	NMUR2NMUR1OPRD1
Substance P SCHEMBL17887651	0.87	OPRD1 (0.67)	NMUR2NMUR1OPRD1
SCHEMBL31332027	0.85	OPRD1 (0.71)	NMUR2NMUR1OPRD1
SCHEMBL30342262	0.85	OPRD1 (0.71)	NMUR2NMUR1OPRD1
SCHEMBL30013957	0.84	OPRD1 (0.63)	NMUR2NMUR1OPRD1APLNR
SCHEMBL31332128	0.82	KDM1A (0.57)	NMUR2NMUR1OPRD1APLNR
SCHEMBL29369748	0.82	OPRD1 (0.59)	NMUR2NMUR1OPRD1APLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20240374689-A1	HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME	LONGEVITY BIOTECH, INC.	2024-11-14	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20240374689-A1	HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME	SCTR, GIPR, APLNR	NMUR2 664/4885NMUR1 461/4885OPRD1 501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.